Detalhe da pesquisa
1.
Engineering monocyte-derived dendritic cells to secrete interferon-α enhances their ability to promote adaptive and innate anti-tumor immune effector functions.
Cancer Immunol Immunother
; 64(7): 831-42, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25863943
2.
HPV vaccine stimulates cytotoxic activity of killer dendritic cells and natural killer cells against HPV-positive tumour cells.
J Cell Mol Med
; 18(7): 1372-80, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24979331
3.
Except for C-C chemokine receptor 7 expression, monocyte-derived dendritic cells from patients with multiple sclerosis are functionally comparable to those of healthy controls.
Cytotherapy
; 16(7): 1024-30, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24856897
4.
Circulating dendritic cells of multiple sclerosis patients are proinflammatory and their frequency is correlated with MS-associated genetic risk factors.
Mult Scler
; 20(5): 548-57, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24057429
5.
Active specific immunotherapy targeting the Wilms' tumor protein 1 (WT1) for patients with hematological malignancies and solid tumors: lessons from early clinical trials.
Oncologist
; 17(2): 250-9, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22291091
6.
NK cells: key to success of DC-based cancer vaccines?
Oncologist
; 17(10): 1256-70, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22907975
7.
Interleukin-12p70 expression by dendritic cells of HIV-1-infected patients fails to stimulate gag-specific immune responses.
Clin Dev Immunol
; 2012: 184979, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22844321
8.
Clinical evaluation of cellular immunotherapy in acute myeloid leukaemia.
Cancer Immunol Immunother
; 60(6): 757-69, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21519825
9.
Dendritic cell vaccine therapy for acute myeloid leukemia: questions and answers.
Hum Vaccin
; 7(5): 579-84, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21422813
10.
The Ins and Outs of Messenger RNA Electroporation for Physical Gene Delivery in Immune Cell-Based Therapy.
Pharmaceutics
; 13(3)2021 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33809779
11.
The Toll-like receptor 7/8 agonist resiquimod greatly increases the immunostimulatory capacity of human acute myeloid leukemia cells.
Cancer Immunol Immunother
; 59(1): 35-46, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19449004
12.
Immunotherapy of acute myeloid leukemia: current approaches.
Oncologist
; 14(3): 240-52, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19289488
13.
Clinical-grade manufacturing of autologous mature mRNA-electroporated dendritic cells and safety testing in acute myeloid leukemia patients in a phase I dose-escalation clinical trial.
Cytotherapy
; 11(5): 653-68, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19530029
14.
Human C-reactive protein activates monocyte-derived dendritic cells and induces dendritic cell-mediated T-cell activation.
Arterioscler Thromb Vasc Biol
; 28(3): 511-8, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18218989
15.
Chimeric Antigen Receptor-Modified T Cell Therapy in Multiple Myeloma: Beyond B Cell Maturation Antigen.
Front Immunol
; 10: 1613, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31379824
16.
The use of TLR7 and TLR8 ligands for the enhancement of cancer immunotherapy.
Oncologist
; 13(8): 859-75, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18701762
17.
A maximal exercise bout increases the number of circulating CD34+/KDR+ endothelial progenitor cells in healthy subjects. Relation with lipid profile.
J Appl Physiol (1985)
; 104(4): 1006-13, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18218912
18.
Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cells.
J Leukoc Biol
; 82(6): 1365-74, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17711977
19.
Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer.
Front Immunol
; 9: 394, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29599770
20.
A versatile T cell-based assay to assess therapeutic antigen-specific PD-1-targeted approaches.
Oncotarget
; 9(45): 27797-27808, 2018 Jun 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29963238